Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting

NCT04181346 is registered in ClinicalTrials.gov with Faculdade de Medicina do ABC as lead sponsor.

NCT NCT04181346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04181346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting
Lead sponsor
Faculdade de Medicina do ABC
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2019
Completion date
February 28, 2020
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea